Welcome to Reaxense Inc.!
Reaxense, an Ontario-based private chemical and biotechnology corporation, is offering a comprehensive product range in medicinal chemistry, drug discovery and custom synthesis as well as supplying innovative chemical building blocks and intermediates for the pharmaceutical, biotechnology, chemical, government, and academic sectors.
To utilize regulatory roles and functions of pseudokinases, Reaxense is also developing a portfolio of novel pseudokinase inhibitors.
As a separate line of business, Reaxense’s high-profile panel of experts is providing environmental and business consulting services to international companies and governmental agencies working on oil, gas and mining projects in Eastern Europe.
Reaxense was founded in 2011 and it is headquartered in Toronto, Ontario, Canada.